Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon confirm that.

In an analysis of health data from 130million people, British researchers found medications which could potentially increase, ...

In an analysis of health data from 130million people, British researchers found medications which could potentially increase, ...

In all, researchers found that people taking GLP-1 medications had lower risks for 42 health outcomes, including liver ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

A large study published in Nature Medicine reviewed the effects of GLP-1 drugs like Ozempic and Mounjaro on 175 different health outcomes. The findings show benefits for brain and heart health, but ...

There are two kinds of risk factors for dementia: non-modifiable and modifiable. Non-modifiable risk factors are ones that cannot be changed or eliminated, like aging, family history and genetics.

About half of new patients will survive another five years after being diagnosed with dementia, according to a large new study that indicates there are major differences based on their age at ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. Progress in dementia ...

Care and cure magazine - Spring 2015 A large-scale study in the US has suggested a link between dementia and certain drugs, including some sleep aids and hay fever treatments. The researchers studied ...

Paralytic drugs, or neuromuscular blocking agents (NMBAs), are powerful muscle relaxants used to prevent muscle movement during surgical procedures. They're also used during critical care, such as ...

Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs for obesity ... A Rise in Dementia: By 2060, new U.S. dementia cases ...